A5013277370- Vestibular and auditory disorders
- Hearing, Cochlea, Tinnitus, Genetics
- Head and Neck Cancer Studies
- Hearing Loss and Rehabilitation
- Tracheal and airway disorders
- Salivary Gland Tumors Diagnosis and Treatment
- Ear Surgery and Otitis Media
- Ear and Head Tumors
- Obstructive Sleep Apnea Research
- Dysphagia Assessment and Management
- Voice and Speech Disorders
- Vasculitis and related conditions
- Oral and Maxillofacial Pathology
- Neuroscience of respiration and sleep
- Noise Effects and Management
- Allergic Rhinitis and Sensitization
- Sinusitis and nasal conditions
- Diet and metabolism studies
- Olfactory and Sensory Function Studies
- Cancer Diagnosis and Treatment
- Asthma and respiratory diseases
- Otitis Media and Relapsing Polychondritis
- Liver Disease Diagnosis and Treatment
- Sarcoma Diagnosis and Treatment
- Cerebral Venous Sinus Thrombosis
Sapienza University of Rome
2016-2025
Azienda Ospedaliero-Universitaria Policlinico - Vittorio Emanuele
2025
University of Catania
2021-2025
Policlinico Umberto I
2015-2024
Policlinico Universitario di Catania
2024
Casa Sollievo della Sofferenza
2016-2024
Istituti di Ricovero e Cura a Carattere Scientifico
2021-2024
Hospital Sant Joan de Déu Barcelona
2008-2023
Universidad de Sevilla
2021
All India Institute of Medical Sciences Jodhpur
2020
To characterize swallowing deficits in amyotrophic lateral sclerosis (ALS); investigate the delay dysphagia onset; estimate correlations between severity and patients' functional status; identify symptom(s) most likely to predict dysphagia.A group of 49 consecutive patients with ALS, 14 bulbar onset 35 spinal onset, underwent evaluation including bedside fiberoptic endoscopic examination detect dysphagia.Patients were more than those without have ALS (P = 0.02); severely impaired chewing...
To evaluate the role of clinical scores assessing risk disease severity in patients with suspicion obstructive sleep apnea syndrome (OSA). The hypothesis was tested by applying artificial intelligence (AI) to demonstrate its effectiveness distinguishing between mild-moderate OSA and severe risk.A support vector machine model (SVM) developed from samples included analysis (N = 498), they were split into 75% for training 373) remaining testing 125). Two diagnostic thresholds selected severity:...
Pulmonary embolism (PE) ranks as a leading cause of in-hospital mortality and the third most common cardiovascular death. The spectrum PE manifestations varies widely, making it difficult to determine best treatment approach for specific patients. Conventional options include anticoagulation, thrombolysis, or surgery, but emerging percutaneous interventional procedures are being investigated their potential benefits in heterogeneous populations. These novel techniques encompass...